Please enter a keyword
EN
CN
JP
About Sungen
Company Profile
Milestones
Social Responsibilities
Contact Us
Join Us
Research & Development
Research Platforms
Research Centers
Research Institutes
New Raw Materials of Pharmaceutical
Innovative Manufacture
Lighthouse Factory
Biofabrication
Key Control System
Quality Management
Authoritative Certification
Clinical Research
Real-World Study
Research Fund
Research Papers Published
Brand ANI
Products
Company Profile
Sungen, a company for innovation driven fermentation products, focuses on peptide drugs and biological fermentation technology. Sungen is a national high-tech enterprise, the original research and production enterprise of nattokinase and natural vitamin K2 (MK-7) in China, and the demonstration base of production quality management of physiologically active substances (such as nattokinase, natural vitamin K2 γ- Polyglutamic acid, etc.).
Sungen takes biological fermentation manufacturing as the core, covering the fields of new drugs, nutrition and health products, skin care products and so on. It has a whole industrial chain of strain fermentation, raw material R & D and manufacturing and terminal preparations. It is a raw material manufacturer and product provider of nattokinase, natural vitamin K2 (MK-7) and food grade hyaluronic acid in China.
100,000 Class
GMP Clean workshop
10,000+
Microbiological testing room
30%
Scientific research team and expert team in research account for 30%
6200+
Bacterial strain in store
10%
10% of the sales revenue is invested in scientific research and development every year
90%
More than 90% of patents are for invention
Milestones
2022
New discoveries - Make life more exciting - Vitamin K2 expert exchange meeting of public welfare project was held in Beijing
Nanao Nattokinase Scientists Forum and "Natto Powder" Group Standard Release Conference were successfully held
The "Expert Suggestions on the Application of Nattokinase in Risk Groups of Vascular Diseases (2020 Edition) " was officially released in cooperation with the Beijing Neurological Society
The T/CQAP group standard of "Natto Powder" (2001-2022) was officially released and implemented in conjunction with the Pharmaceutical Quality Management Association of China
On the first anniversary of the establishment of "Kangbai Micro-ecology Fund", Sungen donated 2 million yuan to increase the capital
Launched the “Columbus Project of Probiotic” to openly collect clinical research projects on probiotics
2021
Establish the “Kangbai Micro-ecology Fund”
Breakthrough in scientific research achievements of 120 billion active probiotics
Obtain license of sodium hyaluronate food production. Launch food grade sodium hyaluronate raw material HAUni ™
Establish “The Research Center of HA Food Application", jointing Junyue Health
Publish the book “Clinial Vitamin K2 Theory”
Launch the public welfare activities "NOT WITHOUT YOU, Caring for cardiovascular and cerebrovascular health”
Establish Sungen Shanghai office
See more
2020
Publish scientific research achievements of 120 billion active probiotics
Start the special fund for nutrition promotion of China Health Promotion Foundation - Sungen scientific research fund project of vitamin K2
The first expert seminar on "The Application of Nattokinase in People at Risk of Vascular Disease” (2020 Edition) was held jointly with Beijing Society of Neurology
2019
Formulate the “Local Food Safety Standard of Guangdong Province-natto Powder”, and unify the activity detection standard of nattokinase in domestic
Successfully developed international single crystal of vitamin K2 and high activity odorless raw materials of nattokinase
Cooperate with Shenyang Pharmaceutical University to develop "Class I new biological products about nattokinase injection and oral preparation"
The book "Expert Consensus on the Role of Vitamin K2 in Disease Prevention and Treatment" was published
Awarded CNIC 2019 “Award for Health Industry Ingenuity Enterprise "
Sungen scientific research fund project of vitamin K2 was selected as “Top Ten Positive Energy Events in Nutrition and Health Market in 2019"
Raw material of vitamin K2 (MK-7) was rated as "High-tech Product in Guangdong" in 2019
2018
Establish “Antithrombotic and Thrombolytic Innovative Drug Research Center of Sungen-Shenyang Pharmaceutical University "
Publish the popular science book “Vitamin K2 -- A Forgotten Vitamin"
Awarded CNIC 2018 “Industry Promotion Award of Vitamin K2 "
Sunshine consumption and multi center clinical real world research action were selected as “Top Ten Positive Energy Events in Nutrition and Health Market in 2018 "
2017
Establish the “Vitamin K2 Research Fund" and launch the first batch research projects of vitamin K2
Awarded the title of “Production Management Demonstration Base of Natto Physiological Active Substance" in Chinese mainland
Inaugurate the "Vitamin K2 Research Center" and launch the first six vitamin K2 research projects
Publish book “Clinical Data Collection”
2016
Purification technology of vitamin K2 has won the national invention patent, and vitamin K2 has obtained the EU new resource food certification
The application for vitamin K2 included in the national nutrition fortifier catalogue (14880) was officially approved
Obtained the first production license of vitamin K2 in China
2015
Obtain first export health certificate of vitamin K2 in China and become the first enterprise to officially declare for export in the name of vitamin K2 in China
Apply for EU new resource food certification and US FDA certification
2014
Pass ISO and HACCP double certification
2012
Awarded the title of “Production Quality Management Demonstration Base of Nattokinase " in China
Establish the "Pamir Plateau Institute of Medicinal Plants" with Xinjiang Uygur Institute of medicine
The preclinical study of a new anticancer drug Weikang alcohol was approved as a project of major new anticancer drug in Guangdong Province
Nattokinase, a new thrombolytic drug, was approved as a research project of major new cardiovascular and cerebrovascular drugs in Guangdong Province
2011
The Organizing Committee of the high tech fair rated Chongjian series products as "High-tech Achievements" and designated them as participating health products
Be rated as a national high-tech enterprise
2006-2010
"Production of paclitaxel by fermentation of genetically engineered strain ST026 "won the bid for " Key breakthrough projects in key fields in Guangdong and Hong Kong in 2006 "
Become the flagship manufacturer of raw materials of nattokinase (EsseZyme ™） and natural vitamin K2 (ESSEK2™） in China
Pass GMP / QS certification
"Production of paclitaxel by fermentation of genetically engineered strain ST026 " has won 4 invention patents at home and abroad
Weikang alcohol, a new anticancer active molecule, has won the national major research and development project of new anticancer drugs, and four invention patents at home and abroad
Become a Chinese mainland member unit of Taiwan nattokinase Association
2000-2005
Complete the acceptance of the project of Ministry of Science and Technology "Production of anticancer drug paclitaxel by fermentation with genetic engineering strain Phargen AA-026"
Sign the agreement on co-construction of “Joint Laboratory of secondary metabolism engineering” with Institute of Botany, Chinese Academy of Sciences
Sign "the cooperation agreement of Anticoagulant drug - genetically engineered recombinant hirudin (Zhibaosu™，Hirudin ™）" with Peking University
1989-1999
"Production of anticancer drug paclitaxel by fermentation with genetic engineering strain Phargen AA-026" won the first batch of financial support of the innovation fund project of the Ministry of scientific research in China
Discover a new anticancer drug molecule Weikang alcohol, complete the structure confirmation and apply for invention patent
Pilot studies and approvals of genetically engineered peptide drugs G-CSF and IL-1ra
Dr. Chen Jiepengs team conduct peptide drugs and paclitaxel research projects at Peking University
2022
2021
2020
2019
2018
2017
2016
2015
2014
2012
2011
2006-2010
2000-2005
1989-1999
Contact Us
Headquarters
Shanghai Office
Address:
Sungenbio Park, Free Trade Zone， Shantou Guangdong, China
Tel：
0086-754-88819999-8807
Fax：
0086-754-83595599
E-mail：
sungenbio@163.com
Address:
Room 703, 7/F, building B, Jiuxing business center，No. 9， Shenbin Road, Minhang District, Shanghai
Tel:
0086-21-54399538
Email:
sales02_ sungen@163.com
Are there any other problems? Please leave your message and we will have someone to contact you
Online Contact
Online Message
Are there any other problems? Please leave your message and we will have someone to contact you.
About Us
Research & Development
Innovative Manufacture
Clinical Research
Brand ANI
Products
Join Us
COPYRIGHT © 2019 Guangdong Sungen Bioscience Co., Ltd.
Guangdong ICP 15051377-4
Powered by Fractal-technology
The basic information